Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep 1;20(1):138.
doi: 10.1186/s13020-025-01204-z.

Potential of phytochemicals in the treatment of Alzheimer disease by modulating lysosomal dysfunction: a systematic review

Affiliations
Review

Potential of phytochemicals in the treatment of Alzheimer disease by modulating lysosomal dysfunction: a systematic review

Man Yuan et al. Chin Med. .

Abstract

Alzheimer disease (AD) is a primary international health dilemma, especially in elderly populations, due to its progressive nature and its adverse cognitive impact. The dysfunction of lysosomes, which impairs protein degradation and leads to toxic accumulation in neurons, is a pivotal factor in AD. We explore phytochemicals that specifically target lysosomal dysfunction via the activation of autophagy, phagocytosis, and lysosome function, exhibiting anti-inflammatory and antioxidant properties. This study involves extracting and evaluating phytochemicals by exploring multiple databases, Google Scholar, PubMed, the Science Citation Index Expanded (SCIE), and the China National Knowledge Infrastructure (CNKI), integrating contemporary biochemical evidence with TCM principles-highlighting the interconnected roles of deficiency, stasis, and phlegm-to provide a comprehensive therapeutic framework. Key phytochemicals-magnolol, trehalose, and salidroside- demonstrate notable promise in enhancing lysosomal function, reducing amyloid beta accumulation, and improving cognitive outcomes. Addressing traditional theory and modern science, we underline the potential for future research by clarifying the mechanisms of compounds and their effectiveness, which may delay the disease process.

Keywords: Alzheimer disease; Autophagy; Lysosomes; Phagocytosis; Phytochemicals.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Prisma Flow Chart
Fig. 2
Fig. 2
Pathological processes in Alzheimer Disease
Fig. 3
Fig. 3
Overview of autophagy pathways
Fig. 4
Fig. 4
Network Map of Phytochemical–Protein Interactions Targeting Lysosomal Dysfunction and anti‑inflammatory/antioxidant pathways for Alzheimer Disease therapy. Cluster 1 (left, ~ 50 nodes; orange gradient) groups phytochemicals that exhibit lysosome‑restorative, anti‑inflammatory, and/or antioxidant activity. Cluster 2 (right, ~ 45 nodes; darker orange‑brown) contains key pathological and signalling mediators enriched in lysosomal and autophagy‑related proteins/enzymes. Notes: “↑” represents the up-regulated targets, “↓” represents the down-regulated targets

Similar articles

References

    1. Hampel H, Hardy J, Blennow K, et al. The amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry. 2021;26:5481–503. - PMC - PubMed
    1. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021;397:1577–90. - PMC - PubMed
    1. Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33. 10.1038/s41572-021-00269-y. - PMC - PubMed
    1. Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University–<em>Lancet</em> commission. Lancet. 2022;400:1967–2006. 10.1016/S0140-6736(22)01546-X. - PMC - PubMed
    1. Passeri E, Elkhoury K, Morsink M, et al. Alzheimer’s disease: treatment strategies and their limitations. Int J Mol Sci. 2022. 10.3390/ijms232213954. - PMC - PubMed

LinkOut - more resources